Nrc Health (NRC) EBITDA (2010 - 2026)

Nrc Health has disclosed EBITDA across 17 years of filings, most recently posting -$3.2 million for Q2 2026.

• In Q2 2026, EBITDA fell 303.9% year-over-year to -$3.2 million; the TTM figure through Jun 2026 stood at $14.7 million (down 46.89% YoY), while the FY2025 annual figure was $22.6 million, down 35.81% from the prior year.
• EBITDA came in at -$3.2 million for Q2 2026 at Nrc Health, down from $5.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $12.2 million in Q4 2022 to a low of -$3.2 million in Q2 2026.
• Average EBITDA over 5 years is $8.2 million, with a median of $8.9 million recorded in 2023.
• Year-over-year, EBITDA decreased 1.87% in 2025 and plunged 303.9% in 2026.
• Over 5 years, EBITDA stood at $12.2 million in 2022, then retreated by 4.35% to $11.7 million in 2023, then fell by 18.11% to $9.6 million in 2024, then slumped by 51.3% to $4.7 million in 2025, then plunged by 169.35% to -$3.2 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$3.2 million in Q2 2026, $5.6 million in Q1 2026, and $4.7 million in Q4 2025.